323 related articles for article (PubMed ID: 31404109)
1. Pharmaceuticals imports in Tanzania: Overview of private sector market size, share, growth and projected trends to 2021.
Wande DP; Sangeda RZ; Tibalinda P; Mutta IK; Mkumbwa S; Bitegeko A; Kaale E
PLoS One; 2019; 14(8):e0220701. PubMed ID: 31404109
[TBL] [Abstract][Full Text] [Related]
2. [An analysis of the pharmaceuticals market in Vietnam].
Simonet D
Sante; 2001; 11(3):155-60. PubMed ID: 11641078
[TBL] [Abstract][Full Text] [Related]
3. What happened to anti-malarial markets after the Affordable Medicines Facility-malaria pilot? Trends in ACT availability, price and market share from five African countries under continuation of the private sector co-payment mechanism.
; Tougher S; Hanson K; Goodman C
Malar J; 2017 Apr; 16(1):173. PubMed ID: 28441956
[TBL] [Abstract][Full Text] [Related]
4. Testing times: trends in availability, price, and market share of malaria diagnostics in the public and private healthcare sector across eight sub-Saharan African countries from 2009 to 2015.
; Hanson K; Goodman C
Malar J; 2017 May; 16(1):205. PubMed ID: 28526075
[TBL] [Abstract][Full Text] [Related]
5. The malaria testing and treatment landscape in mainland Tanzania, 2016.
; Michael D; Mkunde SP
Malar J; 2017 Apr; 16(1):202. PubMed ID: 28521811
[TBL] [Abstract][Full Text] [Related]
6. A new approach to gathering pharmaceutical market data to support policy implementation and access to medicines: as demonstrated by malaria medicines in Zambia.
Coghlan R; Stephens P; Mwale B; Siyanga M
Malar J; 2018 Nov; 17(1):444. PubMed ID: 30497504
[TBL] [Abstract][Full Text] [Related]
7. [Economic determinants of the demand for importation of pharmacochemical and pharmaceutical products].
Santos AMAD; Tejada CAO; Jacinto PA
Cad Saude Publica; 2017 Sep; 33(9):e00087916. PubMed ID: 28977272
[TBL] [Abstract][Full Text] [Related]
8. The market dynamics of selective serotonin re-uptake inhibitors: a private sector study in South Africa.
Oosthuizen F; Kondiah PJ; Moosa HB; Naroth S; Patel NI; Reddy D; Soobramoney A
Afr Health Sci; 2017 Dec; 17(4):1197-1202. PubMed ID: 29937892
[TBL] [Abstract][Full Text] [Related]
9. The economics of pharmaceutical supply in Tanzania.
Yudkin JS
Int J Health Serv; 1980; 10(3):455-77. PubMed ID: 7419314
[TBL] [Abstract][Full Text] [Related]
10. In-kind drug donations for Tanzania. Stakeholders' views--a questionnaire survey.
Mariacher GG; Mtasiwa D; Wiedenmayer K; Bruppacher R; Tanner M; Hersberger KE
World Health Popul; 2007 Jan; 9(1):74-99. PubMed ID: 18270501
[TBL] [Abstract][Full Text] [Related]
11. Assessing public-private procurement practices for medical commodities in Dar Es Salaam: a situation analysis.
Mbwasi R; Mbepera D; Mfuko W; Makanzo J; Kikwale M; Canavan R; Stoermer M; Wiedenmayer K
BMC Health Serv Res; 2022 Dec; 22(1):1523. PubMed ID: 36517787
[TBL] [Abstract][Full Text] [Related]
12. Local production of pharmaceuticals in Africa and access to essential medicines: 'urban bias' in access to imported medicines in Tanzania and its policy implications.
Mujinja PG; Mackintosh M; Justin-Temu M; Wuyts M
Global Health; 2014 Mar; 10():12. PubMed ID: 24612518
[TBL] [Abstract][Full Text] [Related]
13. [Study on the availability and cost of medicines in the private sector in Mali].
Maïga MD; Diawara A
Med Trop (Mars); 2006 Dec; 66(6):565-8. PubMed ID: 17286022
[TBL] [Abstract][Full Text] [Related]
14. Prices and availability of locally produced and imported medicines in Ethiopia and Tanzania.
Ewen M; Kaplan W; Gedif T; Justin-Temu M; Vialle-Valentin C; Mirza Z; Regeer B; Zweekhorst M; Laing R
J Pharm Policy Pract; 2017; 10():7. PubMed ID: 28116107
[TBL] [Abstract][Full Text] [Related]
15. Parallel imports and innovation in an emerging economy: the case of Indian pharmaceuticals.
Mantovani A; Naghavi A
Health Econ; 2012 Nov; 21(11):1286-99. PubMed ID: 23027711
[TBL] [Abstract][Full Text] [Related]
16. Access to Veterinary Drugs in Sub-Saharan Africa: Roadblocks and Current Solutions.
Jaime G; Hobeika A; Figuié M
Front Vet Sci; 2021; 8():558973. PubMed ID: 35356415
[TBL] [Abstract][Full Text] [Related]
17. The market dynamics of generic medicines in the private sector of 19 low and middle income countries between 2001 and 2011: a descriptive time series analysis.
Kaplan WA; Wirtz VJ; Stephens P
PLoS One; 2013; 8(9):e74399. PubMed ID: 24098644
[TBL] [Abstract][Full Text] [Related]
18. A Study of Comparative Advantage and Intra-Industry Trade in the Pharmaceutical Industry of Iran.
Yusefzadeh H; Rezapour A; Lotfi F; Ebadifard Azar F; Nabilo B; Abolghasem Gorji H; Hadian M; Shahidisadeghi N; Karami A
Glob J Health Sci; 2015 Apr; 7(6):295-307. PubMed ID: 26153184
[TBL] [Abstract][Full Text] [Related]
19. Research Letter: Antihypertensive Drugs Market in India: An Insight on Size, Trends, and Prescribing Preferences in the Private Health Sector, 2016-2018.
Sahoo SK; Pathni AK; Krishna A; Moran AE; Cohn J; Bhatia S; Maheshwari N; Sharma B
Glob Heart; 2021; 16(1):51. PubMed ID: 34381673
[TBL] [Abstract][Full Text] [Related]
20. Parallel imports and the pricing of pharmaceutical products: evidence from the European Union.
Ganslandt M; Maskus KE
J Health Econ; 2004 Sep; 23(5):1035-57. PubMed ID: 15353192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
